Figure 3.
Scaffold (left) and binding sites (right): (A) aknadicine, (B) 16beta-hydroxy-19s-vindolinine N-oxide, (C) the control, SB-590885.
Note: Key position of the binding sites was set at the residues 530–535.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.